News

Cambridge, UK, 6 May 2025 – Healx, a leader in AI-driven drug discovery for rare diseases, is pleased to announce the appointment of Christopher Moertel, M.D., as its new Global Head of Clinical Development. Dr. Moertel, a highly respected expert in the field, brings a wealth of experience in clinical research and drug development, particularly … Continued

NF1 is a debilitating rare genetic disorder that causes tumours to form along nerves, often manifesting in childhood. It affects approximately one in 2,500 individuals worldwide and can lead to severe complications, including pain, disfigurement, and malignancies. Despite its impact, treatment options remain limited, with many patients facing invasive surgeries or therapies with severe side … Continued